Vonsetamig is a bispecific antibody comprising humanized immunoglobulin G4-kappa that targets both TNFRSF17 and CD3E. This therapeutic antibody is designed to act as an antineoplastic agent, leveraging its dual specificity to modulate immune system responses against cancer cells. Vonsetamig's unique ability to bind to both a tumor necrosis factor receptor superfamily member 17 (TNFRSF17) on malignant cells and the CD3 epsilon (CD3E) on T-cells facilitates a directed immune response towards the tumor environment, making it a critical tool in cancer immunotherapy research.
Vonsetamig is a bispecific antibody comprising humanized immunoglobulin G4-kappa that targets both TNFRSF17 and CD3E. This therapeutic antibody is designed to act as an antineoplastic agent, leveraging its dual specificity to modulate immune system responses against cancer cells. Vonsetamig's unique ability to bind to both a tumor necrosis factor receptor superfamily member 17 (TNFRSF17) on malignant cells and the CD3 epsilon (CD3E) on T-cells facilitates a directed immune response towards the tumor environment, making it a critical tool in cancer immunotherapy research.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
